Title Section, List of contents, Author index and Subject index

Title Section, List of contents, Author index and Subject index

NEUROCHEMISTRY INTERNATIONAL The Journal for the publication of cellular and molecular aspects of neurochemistry in the form of original and rapid res...

760KB Sizes 0 Downloads 65 Views

NEUROCHEMISTRY INTERNATIONAL The Journal for the publication of cellular and molecular aspects of neurochemistry in the form of original and rapid research communications and also critical reviews and commentaries

Title Section, List of Contents Author and Subject Index Volume 1 5 (1 989)

PERGAMON PRESS Oxford

• New

York

• Beijing

• Frankfurt

• Silo

Paulo

• Sydney

. Tokyo

• Toronto

NEUROCHEMISTRY INTERNATIONAL The Journal for the publication of cellular and molecular aspects of neurochemistry in the form of original and rapid research communications and also critical reviews and commentaries E x e c u t i v e Editors For U.K. Also for Reviews, Commentaries and Rapid Reports N. N. Osborne (Chairman): NuffieM Laboratory of Ophthalmology, University of Oxford, Walton Street, Oxford 0)(2 6,414I, U.K. For Europe and Africa: J. Rossier: CNRS Laboratoire de Physiologie Nerveuse, 91190 Gifs u r - Yvette, F r a n c e

For Australasia: G. A. R. Johnston: Department of Pharmacology, University q[" Sydney, Sydney, N S W 2006, Australia

For The Americas: W. Lovenberg: MerrelI-Dow Research Institute, 2110 E. Galbraith Road, Cincinnati, OH 45215, U.S.A. R. Tapia: Instituto de Fisiologia Celular, Universidad Nacional Autonoma, AP 70-600, 04510 Mexico D.F., Mex&o For Asia: K. Kuriyama: Department of Pharmacology, Kyoto Prefectural Universit)' of Medicine, Kawaramachi-Hirokoji, Kamikyo-ku, Kyoto, Japan

Editorial A d v i s o r y B o a r d A. A. AbdeI-Latif, Augusta, Ga R. Balazs, Amsterdam F.J. Barrantes, Argentina T. BartIai, Stockholm J. M, l ~ r r e , Paris H. Breer, Stuttgart S . H . Buck, Cincinnati, Ohio !. Creese, Newark, N.J. W . E . Davies, Birmingham, U.K. J. O. Dolly, London, U.K. G . J . Dockray, Liverpool, U.K. M. Ebadi, Omaha, Neb. M. Fillenz, Oxford, U.K. R. W. Fuller, Indianapolis, Ind. K. G. Fuxe, Stockholm M. Hamon, Paris R. B. Holman, Bristol, U.K. R . J . Huxtable, Tucson, Ariz. M. Israel, Gif-sur-Yvette P . M . luvone, Atlanta, Ga D.M. Jacobowitz, Bethesda, Aid G. Jaim-Eteheverry, Buenos Aires B. Jarrott, Melbourne J. W. Kebubian, Abbott Park, Ill. D. M. Kuhn, Detroit, Mich. P. J. Magistretti, Lausanne A.J. Mandell, La Jolla, Calif. D. Man-Kit Lain, Houston, Tex. N. Morel, Gif-sur- Yvette A. H. Molder, Amsterdam M . R . V . Murthy, Quebec T. Nagatsu, Nagoya N.H. Neff, Columbus, Ohio J . L . Nussbaum, Strasbourg B. Oderfeld-Nowak, Warsaw S.E. Poduslo, Baltimore, Md J.F. Pujol, Lyon M. Raiteri, Genoa S. Rose, Milton Keynes, U.K. R. H. Rotb, New Haven, Conn. E. Sanders-Bush, Nashville, Tenn. M. Satake, Niigata A. Schonsboe, Copenhagen J . E . Schultz, Tfibingen C.R. Snell, London, U.K. T . L . Sourkes, Montreal R. Tanaka, Nagoya G. Tettamanti, Milan P. M. Vanhoutte, Houston, Tex. J. J. Vanderhaeghen, Brussels J.-Y. Wu, Lawrence, Kan. M . B . H . Youdlm, Haifa H. Zimmermann, Frankfurt Aims and Scope: Neurochemistry International publishes (within 5 months of acceptance) papers primarily concerned with the metabolism and function of the nervous system. Papers are also published which deal with the chemical aspects of the anatomy, pathology, physiology, pharmacology and genetics of the nervous system, as well as the biochemistry of the nervous tissues. The journal also publishes material showing the relationship of fundamental neurochemical observations to basic neurology, neuropharmacology, chemical pathology and neurotransmission of the nervous system. The Executive Editors and Publisher would welcome comments from authors concerning improvements and/or clarification on the aims and scope of the journal.

Publishing Office: Journals Production Unit, Pergamon Press plc, Hennock Road, Marsh Barton, Exeter, Devon EX2 8NE, U.K. (Tel. Exeter (0392) 51558; Telex 42749) Subscription and Advertising Offices: Rest of the World, Pergamon Press plc, Headington Hill Hall, Oxford OX3 0BW, U.K. (Tel. Oxford (0865) 64881; Telex 83177). North America, Pergamon Press Inc., Maxwell House, Fairview Park Elmsford, N Y 10523, U.S.A. Subscription Rates (1990): Annual institutional rate (1990) DM 670.00; 2-year institutional rate (1990/91) DM 1273.00; personal subscription rate for those whose library subscribes at the regular rate (1990) DM t65.00. Special rates for members of the International Society for Neurochemistry and the European Society for Neurochemistry are available on request. All prices are subject to amendment without notice. Ba~k Issues: Back issues of all previously published volumes, in both hard copy and on microform, are available direct from Pergamon Press offices.

Publication Frequency: 2 volumes of 4 issues per volume Copyright ~: 1990. Pergamon Press plc It is a condition of publication that manuscripts submitted to this journal have not been published and will not be simultaneously submitted or published elsewhere. By submitting a manuscript, the authors agree that the copyright for their article is transferred to the copyright owner if and when the article is accepted for publication. However, assignment of copyright is not required from authors who work for organizations which do not permit such assignment. The copyright covers the exclusive rights to reproduce and distribute the article, including reprints, photographic reproductions, microform or any other reproductions of similar nature and translations. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, electrostatic. magnetic tape, mechanical, photocopying, recording or otherwise, without permission in writing from the copyright holder. Photocopying information for users in the U.S.A. The ltem-fec Code for this publication indicates that authorization to photocopy items for internal or personal use is granted by the copyright holder for libraries and other users registered with the Copyright Clearance Center (CCC) Transactional Reporting Service provided the stated fee for copying, beyond that permitted by Section 107 or t08 of the United States Copyright Law, is paid. The appropriate remittance of $3.00 per copy per article is paid directly to the Copyright Clearance Center Inc., 21 Congress Street, Salem, MA 01970. Permission for other use. The copyright owner's consent does not extend to copying for general distribution, for promotion, for creating new works, or for resale. Specific written permission must be obtained from the publisher for such copying. The Item-fee Code for this publication is: 0197-0186/90 $3.00+0.00.

LIST OF CONTENTS VOLUME

15 ( 1 9 8 9 )

Number 1 A. Doble and M. L. Perrier

Pharmacology of excitatory amino acid receptors coupled to inositol phosphate metabolism in neonatal rat striatum

Lia Prado de Carvalho

Modulation of acetylcholine release in rat striatal slices by muscarinic receptors which do not desensitize

Yukio Yoneda, Kiyokazu Ogita, Kisa Yamada, Tomoko Kouda, Takao Ohgaki, Shuji Uchida and Haruo Meguri

17 High concentrations of calmodulin antagonists inhibit accumulation and binding activities of [3H]glutamate in rat brain

P. T.-H. Wong, H. S. Lee, C. H. Tan and W.L. Teo

25

Specific [3H]tryptophan binding sites in rat brain

Masaaki Hirouchi, Ryozo Kuwano, Takashi Katagiri, Yasuo Takahashi and Kinya Kuriyama

33

Nucleotide and deduced amino acid sequences of the GABA A receptor ~t-subunit from human brain

P. P. De Deyn, B. A. Pickut, A. Verzwijvelen, R. D'Hooge, W. Annaert and W. P. De Potter

39 Subcellular distribution and axonal transport of noradrenaline, dopamine-fl-hydroxylase and neuropeptide Y in dog splenic nerve

R. M. Dawson, P. J. Gray, C. M. Upsher and S. Michaelson

49

Katsumichi Takeda, Fumiaka Uchiumi, Masatoshi Takita and Takeshi Kato

55 A rapid enzyme immunoassay for cholectystokinin octapeptide sulfate

Anthony Heape, Fran¢oise Boiron and Claude Cassagne

61

High uptake and rapid metabolism of palmitate in peripheral nerves of normal and Trembler mice in vivo: similarities and differences

Christopher J. Fowler, Cora O'Neill, Per Almqvist, Sofie Nilsson, Birgitta Wiehager and Bengt Winblad

73

Muscarinic receptors coupled to inositol phospholipid breakdown in human SH-SY5Y neuroblastoma cells: effect of retinoic acid-induced differentiation

Sherwin Wilk and Elizabeth K. Wilk

81

Pyroglutamyl peptidase II, a thyrotropin releasing hormone degrading enzyme: purification and specificity studies of the rabbit brain enzyme

G. F. Dunglison, P. A. Wilce and B. C. Shanley

91

Autoradiographic studies on the effect of ethanol on muscarinic receptors in rat brain

Alejandro M. Dopico, Luis M. Zieher, Jos6 Mayo, Noe Altsehiiller, Juan J. L6pez and Guillermo Jaim-Etcheverry

97

Long-term changes in noradrenaline (NA) and dopamine (DA) contents of rat cerebellum following neonatal X-irradiation

L. F. Agnati, K. Fuxe, M. Ruggeri, E. Merlo Pith, F. Benfenati, V. Volterra, U. Ungerstedt and I. Zini

Modification of the kinetic properties of Triton-solubilized rabbit brain acetylcholinesterase by allosteric effectors at low ionic strength

107 Effects of chronic treatment with uridine on striatal dopamine release and dopamine related behaviours in the absence or the presence of chronic treatment with haloperidol iii

Index

iv

Paula Rosario, Ana Barat and Galo Ramirez

115 Characterization of binding sites for [3H]GABA in Drosophila melanogaster CNS membranes 121

Book Reviews

125

News Items

Number 2 Jacqueline M. Evans and Gerald Cohen

127 Commentary: Can trace amounts of neurotoxins destroy dopamine neurons?

Darryle D. Schoepp

131

Yukio Yoneda and Kiyokazu Ogita

137 Characterization of quisqualate-sensitive [3H]glutamate activity solubilized from rat adrenal

Bertrand Lambolez, Claude-Marguerite Deschamps and Jean Rossier

145

Interactions of benzodiazepines and /~-carbolines with a histidine residue of the benzodiazepine receptor

K. Gulya, D. Budai and P. K~isa

153

Muscarinic autoreceptors are differentially affected by selective muscarinic antagonists in rat hippocampus

Z. Rakonczay, P. K~sa and J. R. Wolff

157 Change in the distribution of acetylcholinesterase molecular forms in the rat superior cervical ganglion after NaBr treatment in t,it,o

M. Garcia-Gil, E. Tongiorgi, M. Cattani, G. Cipollini and M. Brunelli

161

cAMP-dependent protein phosphorylation of a 79 kDa protein in segmental ganglia of the leech Hirudo medicinalis

N. Morel, M. Israel, M. Synguelakis and G. Le Gal la Salle

169

Identification of two proteolipid antigens with different localization at Torpedo neuromuscular synapses

Paul Madtes Jr, Geoffry Fuller and Kathleen Gregg

179

Sensitivity of GABA-displaceable [3H]muscimot binding depends upon the composition of the buffering medium

Christina M. Hall and Jan-Olof Karlsson

185 Aleuria lectin remains bound to its receptors during rapid axonal transport in retinal ganglion cells

Rosemary J. Wilkinson and David G. Nicholls

191

Compartmentation of glutamate and aspartate within cerebral cortical synaptosomes: evidence for a non-cytoplasmic origin for the calciumreleasable pool of glutamate

S. J. Taylor, J. Haggblad and S. A. Greenfield

199

Measurement of cholinesterase activity released from the brain "on-line" and in vivo

A. Garzon-Aburbeh, A. W. Lipkowski, D. L. Larson and P. S. Portoghese

207

Transfer of fatty acyl groups from membrane phosphatides to opiate ligands

C. Charriere-Bertrand, G. le Prince, C. Bouchier, C. Fages, M. Tardy and J. Nunez

215

Expression of tubulin, GFAP and of their encoding mRNAs during the proliferation and differentiation of cultured astrocytes

Alessandro Poli, Ottavio Gandolfi, Paola Roncada, Tiziana Guarnieri, Roberta Lucchi and Luigi Villani

223

Reversible effects of 1-methyl-4-phenylpyridinium dopaminergic neurons in goldfish retina

T. J. Montine and T. L. Sourkes

227

Behaviour of ~-methylserotonin in rat brain synaptosomes

R. J. Huxtable, S. Crosswell and D. Parker

233

Phospholipid composition and taurine content of synaptosomes in developing rat brain

Protein kinase C-mediated inhibition of excitatory amino acidstimulated phosphoinositide hydrolysis in the neonatal rat hippocampus binding

ion (MPP +) on

Index

v

Ambrish J. Patel, Anthony Hunt and Jozsef Kiss

239 Neonatal thyroid deficiency has differential effects on cell specific markers for astrocytes and oligodendrocytes in the rat brain

Masako Hagihara, Kennichiro Fujishiro, Akira Takahashi, Makoto Naoi and Toshiharu Nagatsu

249 A Rapid Publication: Cyclosporin A, an immune suppressor, enhanced neurotoxicity of N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) to mice 255 News Items

Number 3 257 Editorial Anna Starzec, Mohieddine Moumni, Gisdle D'Angelo-Bernard, Yannick Lerrant, Marian Jutisz and Raymond Counis

259 Cyclic AMP enhances gene expression, synthesis and release of newly synthesized alpha and luteinizing hormone beta subunits in cultured rat anterior pituitary cells

Chen Chen, Jin Zhang, Govindan Dayanithi, Jean-Didier Vincent and Jean-Marc Israel

265 Cationic currents on identified rat gonadotroph cells maintained in primary culture

B. Sion, E. Saint Dizier, J. Duval and M. L. Thieulant

277

Steroid receptors and regulation of LH and secretogranin II (GP87) secretion in pituitary cell aggregates

Bernardo Pensa, Marco Achilli, Mario Fontana, Anna Maria Caccuri and Doriano Cavallini

285

S-Aminoethyl-L-cysteine transaminase from bovine brain: purification to homogeneity and assay of activity in different regions of the brain

Marshall K. Cheung

293 The specificity of glutamate inhibition of protein synthesis in synaptosomal fractions from rat cerebral cortex

Marika Eller and Jaak J/irv

301

A. Kenessey, M. Banay-Schwartz, T. DeGuzman and A. Lajtha

307 Regional distribution of brain calpastatin and of calpain II. Activity with casein and with endogenous brain protein substrates

Makoto Naoi, Tsutomu Takahashi, Hasan Parvez, Ryosuke Kabeya, Eiich Taguchi, Keiko Yamaguchi, Yoko Hirata, Masayasu Minami and Toshiharu Nagatsu

315

N-Methylisoquinolinium ion as an inhibitor of tyrosine hydroxylas¢, aromatic L-amino acid decarboxylase and monoamine oxidase

Georges Vauquelin, Jacques De Keyser, Banyingela Kanyinda and Maurice Vanhaelen

321

(+)Tetrahydroanisocycline and (+)tetrahydropalmatine binding to D1 and D2 dopaminergic receptors in human putamen

N. A. Sharif, J. L. Nunes, A. D. Michel and R. L. Whiting

325 Comparative properties of the dopamine transport complex in dog and rodent brain: striatal [3H]GBR12935 binding and [3H]dopamine uptake

C. Moret, I. Pastrie and M. Briley

333

Phillip J. Robinson, Donald R. Gehlert, Enrico Sanna and Ingeborg Hanbauer

339 Two fractions enriched for striatal synaptosomes isolated by percoll gradient centrifugation: synaptosome morphology, dopamine and serotonin receptor distribution, and adenylate cyclase activity

Rainer Schwitzkowsky and Lfiszl6 Hetey

349 Characterization of synaptosomal dopamine release in rat and human brain after post-mortem storage and cryopreservation

M. K. Gaitonde and Elizabeth Murray

355 The effect of conditions of homogenization on the activity of pyruvate dehydrogenase and its stability in brain homogenates

Kinetics of N-methylscopolamine interaction with muscarinic receptor from rat cerebral cortex

Effects of scopolamine treatment and lesion of the nucleus basalis upon various cholinergic markers in the rat brain cortex

Index

vi Yoshiyuki Ohmori and Kinya Kuriyama

359

Negative coupling of ~,-aminobutyric acid (GABA)B receptor with phosphatidylinositol turnover in the brain

A. J. Cholewinski, J. C. Reid, A. M. McDermott and G. P. Wilkin

365

Purification of astroglial-cell cultures from rat spinal cord: the use of D-valine to inhibit fibroblast growth

371

Book Reviews

375

News Items

Claudia Martini, Rossella Pacini, Gino Giannaccini and Antonio Lucacchini

377

[3sS]TBPS binding to purified benzodiazepine~GABA ionophore receptor complex: the effect of GABA on the modulation exerted by benzodiazepine site ligands

Lois Winsky, Hiroyasu Nakata and David M. Jacobowitz

381

Identification of a calcium binding protein highly localized to the cochlear nucleus

S. C. R. Lummis and D. B. Sattelle

391

Insect nervous system [3H]saxitoxin binding sites: characterization and target size

Giuseppe Arienti, Giuseppe Fratto, Gian Luigi Piccinin, Maria Teresa Ramacci, Licia Pacifici, Mariangela Rossi and Lanfranco Corazzi

397

Valproic acid and bicuculline affect the formation of glycerolipid in rat brain

Andrzej Szutowicz, Hanna Bielarczyk, Danuta Sosnowska and Barbara Ciszek

403

Regulation of citrate metabolism and acetylcholine synthesis by Ca 2+ in rat brain synaptosomes

M. Thereza R. Perez and Berndt Ehinger

411

Multiple neurotransmitter systems influence the release of adenosine derivatives from the rabbit retina

Junya Tanaka, Kunitoshi Tada, Masatoshi Takeda, Shiro Hariguchi and Tsuyoshi Nishimura

421

Effect of metallic cations and pH on reassembly of glial fibrillary acidic protein

P. C. Hopkins, I. S. Kay and W. E. Davies

429

A rapid method for the determination of taurine in biological tissue

R. Grimaldi, C. G. Eriksson, P. Eneroth, L. F. Agnati and K. Fuxe

433

Evidence for nuclear ornithine decarboxylase activity in different brain regions of the male rat

H~16ne Fournier and Roger F. Butterworth

439

Effects of maternal thiamine deficiency on the development of thiamine-dependent enzymes in regions of the rat brain

H. Lara and J. Belmar

445

Biochemical evidence for the presence of small and large noradrenergic storage vesicles isolated from cat ovary in isoosmotic conditions. Distribution of dopamine-/~-hydroxylase activity

Riccardo Ghidoni, Amelia Fiorilli, Marco Trinchera, Bruno Venerando, Vanna Chigorno and Guido Tettamanti

455

Uptake, cell penetration and metabolic processing of exogenously administered GM 1 ganglioside in rat brain

ltaru Toyoshima, Akio Yamamoto, Osamu Masamune, Shoji Yamada and Mei Satake

467

Difference in phosphorylation of neurofilament proteins in motor neurons and spinal ganglion cells

Bernadette Earley, Anat Biegon and B. E. Leonard

475

Quantitative autoradiographic analysis of muscarinic receptors and quantitative histochemistry of acetylcholinesterase in the rat brain after trimethyltin intoxication

Gary A. Walter and John W. Phillis

485

5-Aminoimidazole-4-carboxamide riboside administration and purine release from the hypoxic/hypotensive rat cerebral cortex

Number 4

Index

vii

Rie Miyoshi, Shozo Kito, Hajime Ishida and Mika Nakashima

493

Modulation of dopamine DI receptor binding by neurotensin in the rat striatum

Masazumi Takeshita, Satoshi Yoshida and Toshitsugu Yubisui

497

Concomitant decrease in the elongation and condensation activities of very-long chain fatty acyl-CoA in jimpy mouse

Q. Pei, T. Zetterstr6m and M. Fillenz

503

Measurement of extracellular 5-HT and 5-HIAA in hippocampus of freely moving rats using microdialysis: long-term applications

A. Szab6, J. Nemcs6k, P. K~sa and K. Gulya

511

Muscarinic cholinergic components in the carp brain

Philippe Mailly, Amena Ben Youn6s-Chennoufi and Suzanne Bon

517

The monoclonal antibodies Elec-39, HNK-I and NC-I recognize common structures in the nervous system and muscles of vertebrates

D. Maysinger, B. Zorc, B. R. Leavitt, I. Butula, F. L. Chubb and A. C. Cuello

531

Structural analogs of hemicholinium: effects on cholinergic and GABAergic markers in the CNS

Jeffrey H. Boatright and P. Michael luvone

541

GABA and the regulation of serotonin N-acetyltransferasc activity in amphibian retina--I. Effects of GABA agonists and antagonists

Jeffrey H. Boatright and P. Michael Iuvone

549

GABA and the regulation of serotonin N-acetyltransferase activity in amphibian retina--II. The role of dopamine

Toshikuni Sasaoka, Norio Kaneda, Yoshikazu Kurosawa, Keisuke Fujita and Toshiharu Nagatsu

555

A Rapid Publication: Structure of human phenylethanolamine Nmethyltransferase gene: existence of two types of mRNA with different transcription initiation sites

Jerzy Z. Nowak and Ewa Zurawska

567

A Rapid Publication: Serotonin N-acetyltransferase (NAT) activity in hen retina and pineal gland: in vivo pharmacological induction at noon and antagonism of the light-evoked suppression at night

575

Book Review

577

News Items

N.C.I. 16/1--1

AUTHOR INDEX Achilli M. 285 Agnati L. F. 107, 433 Almqvist P. 73 Altsch/iller N. 97 Annaert W. 39 Arienti G. 397 Banay-Schwartz M. 307 Barat A. 115 Benfenati F. 107 Belmar J. 445 Biegon A. 475 Bielarczyk H. 403 Boatright J. H. 541, 549 Boiron F. 61 Bon S. 517 Bouchier C. 215 Briley M. 333 Brunelli M. 161 Budai D. 153 Butterworth R. F. 439 Butula I. 531 Caccuri A. M. 285 de Carvalho L. P. 9 Cassagne C. 61 Cattani M. 161 Cavallini D. 285 Charriere-Bertrand C. 215 Chen Chen 265 Cheung M. K. 293 Chigomo V. 455 Cholewinski A. J. 365 Chubb F. L. 531 Cipollini G. 161 Ciszek B. 403 Cohen G. 127 Corazzi L. 397 Counis R. 259 Crosswell S. 233 Cuello A. C. 531 D'Angelo-Bernard G. 259 Davies W. E. 429 Dawson R. M. 49 Dayanithi G. 265 De Deyn P. P. 39 De Keyser J. 321 De Potter W. P. 39 DeGuzman T. 307 Deschamps C.-M. 145 D'Hooge R. 39 Doble A. 1 Dopico A. M. 97 Dunglison G. F. 91 Duval J. 277 Earley B. 475

Ehinger B. 411 Eller M. 301 Eneroth P. 433 Eriksson C. G. 433 Evans J. M. 127 Fages C. 215 Fillenz M. 503 Fiorilli A. 455 Fontana M. 285 Fournier H. 439 Fowler C. J. 73 Fratto G. 397 Fujishiro K. 249 Fujita K. 555 Fuller G. 179 Fuxe K. 107, 433 Gaitonde M. K. 355 Gandolfi O. 223 Garcia-Gil M. 161 Garzon-Aburbeh A. 207 Gehlert D. R. 339 Ghidoni R. 455 Giannaccini A. 377 Gray P. J. 49 Greenfield S. A. 199 Gregg K. 179 Grimaldi R. 433 Guarnieri T. 223 Gulya K. 153, 511 Haggblad J. 199 Hagihara M. 249 Hall C. M. 185 Hanbauer I. 339 Hariguchi S. 421 Heape A. 61 Hetey L. 349 Hirata Y. 315 Hirouchi M. 33 Hopkins P. C. 429 Hunt A. 239 Huxtable R. J. 233 Ishida H. 493 Israel J.-M. 265 Israel M. 169 Iuvone P. M. 541, 549 Jacobowitz D. M. 381 Jaim-Etcheverry G. 97 J/irv J. 301 Jin Zhang 265 Jutisz M. 259 Kabeya R. 315 Kaneda N. 555 ix

Kanyinda B. 321 Karlsson J.-O. 185 K~isa P. 153, 157, 511 Katagiri T. 33 Kato T. 55 Kay I. S. 429 Kenessey A. 307 Kiss J. 239 Kito S. 493 Kouda T. 17 Kuriyama K. 33, 359 Kurosawa Y. 555 Kuwano R. 33 Lajtha A. 307 Lambolez B. 145 Lara H. 445 Larson D. L. 207 Leavitt B. R. 531 Lee H. S. 25 Le Gal la Salle G. 169 Leonard B. E. 475 Lerrant Y. 259 Lipkowski A. W. 207 L6pez J. J. $7 Lucacchini A. 377 Lucchi R. 223 Lummis S. C. R. 391 Madtes P. Jr 179 Mailly P. 517 Martini C. 377 Masamune O. 467 Mayo J. 97 Maysinger D. 531 McDermott A. M. 365 Meguri H. 17 Merlo Pich E. 107 Michaelson S. 49 Michel A. D. 325 Minami M. 315 Miyoshi R. 493 Montine T. J. 227 Morel N. 169 Moret C. 333 Moumni M. 259 Murray E. 355 Nagatsu T. 249, 315, 555 Nakashima M. 493 Nakata H. 381 Naoi M. 249, 315 Nemcs6k J. 511 Nicholls D. G. 191 Nilsson S. 73 Nishimura T. 421 Nowak J. Z. 567 Nunes J. L. 325

x Nunez J. 215 Ogita K. 17, 137 Ohgaki T. 17 Ohmori Y. 359 O'Neill C. 73 Pacifici L. 397 Pacini R. 377 Parker D. 233 Parvez H. 315 Pastrie I. 333 Patel A. J. 239 Pei Q. 503 Pensa B. 285 Perez M. T. R. 411 Perrier M. L. I Phillis J. W. 485 Piccinin G. L. 397 Pickut B. A. 39 Poli A. 223 Portoghese P. S. 207 le Prince G. 215

Index Sasaoka T. 555 Satake M. 467 Sattelle D. B. 391 Schoepp D. D. 131 Schwitzkowsky R. 349 Shanley B. C. 91 Sharif N. A. 325 Sion B. 277 Sosnowska D. 403 Sourkes T. L. 227 Starzec A. 259 Synguelakis M. 169 Szab6 A. 51 l Szutowicz A. 403

Rakonczay Z. 157 Ramacci M. T. 397 Ramirez G. 115 Reid J. C. 365 Robinson P. J. 339 Roncada P. 223 Rosario P. 115 Rossi M. 397 Rossier J. 145 Ruggeri M. 107

Tada K. 421 Taguchi E. 315 Takahashi A. 249 Takahashi T. 315 Takahashi Y. 33 Takeda K. 55 Takeda M. 421 Takeshita M. 497 Takita M. 55 Tan C. H. 25 Tanaka J. 421 Tardy M. 215 Taylor S. J. 199 Teo W. L. 25 Tettamanti G. 455 Thieulant M. L. 277 Tongiorgi E. 161 Toyoshima I. 467 Trinchera M. 455

Saint Dizier E. 277 Sanna E. 339

Uchida S. 17 Uchiumi F. 55

Ungerstedt U. 107 Upsher C. M. 49 Vanhaelen M. 321 Vauquelin G. 321 Venerando B. 455 Verzwijvelen A. 39 Villani L. 223 Vincent J.-D. 265 Volterra V. 107 Walter G. A. 485 Whiting R. L. 325 Wiehager B. 73 Wilce P. A. 91 Wilk E. K. 81 Wilk S. 81 Wilkin G. P. 365 Wilkinson R. J. 191 Winblad B. 73 Winsky L. 381 Wolff J. R. 157 Wong P. T.-H. 25 Yamada K. 17 Yamada S. 467 Yamaguchi K. 315 Y a m a m o t o A. 467 Yoneda Y. 17, 137 Yoshida S. 497 Younds-Chennoufi A. B. 517 Yubisui T. 497 Zetterstr6m T. 503 Zieher L. M. 97 Zini 1. 107 Zorc B. 531 Zurawska E. 567

SUBJECT INDEX Acetylcholinesterase - in c a r p b r a i n , 511 Acetylcholine - in c a r p brain, 511 Acetylcholine release, 9 Acetylcholine release - modulation by muscarinic receptors, 9 Acetylcholine s y n t h e s i s - e f f e c t of c a l c i u m , 403 Acetylcholine s y n t h e s i s - in s y n a p t o s o m e s , 403 Acetylcholinesterase - a l l o s t e r i c p r o p e r t i e s , 49 Acetylcholinesterase characterisation of Triton solubilised form, 49 Acetylcholinesterase - e f f e c t of NaBr, 157 Acetylcholinesterase - e f f e c t of t r i m e t h y l t i n i n t o x i c a t i o n , 475 Acetylcholinesterase - histochemistry, 475 Acetylcholinesterase - in s u p e r i o r c e r v i c a l g a n g l i o n , 157 Acetylcholinesterase - k i n e t i c p r o p e r t i e s , 49 Acetylcholinesterase - m o l e c u l a r forms, 157 Acetylcholinesterase - m o n o c l o n a l a n t i b o d i e s , 517 A d e n o s i n e d e r i v a t i v e s - r e l e a s e , 411 A d e n y l a t e c y c l a s e a c t i v i t y - in s y n a p t o s o m e s , 339 A l e u r i a l e c t i n - b i n d s to r e c e p t o r s , 185 5-aminoimidazole-4-carboxamide riboside - effect on purine r e l e a s e , 485 S-aminoethyl-L-cysteine transaminase purification and characterisation, 285 A n t i b o d i e s - to p r o t e o l i p i d s , 169 Aromatic-L-amino acid decarboxylase inhibited by Nmethyliosolinuim, 315 A s t r o c y t e c u l t u r e s - e x p r e s s i o n of m R N A s , 215 A s t r o c y t e s - e f f e c t of t h y r o i d d e f i c i e n c y on cell, 239 A s t r o g l i a l cell c u l t u r e s - f r o m s p i n a l cord, 365 Autoradiography - of m u s c a r i n i c r e c e p t o r s , 91, 475 A x o n a l t r a n s p o r t - in r e t i n a l g a n g l i o n cells, 185 A x o n a l t r a n s p o r t - Of A l e u r i a l e c t i n r e c e p t o r s , 185 A x o n a l t r a n s p o r t - of n o r a d r e n a l i n e , dopamine-hydroxylase and NPY, 39 A x o n a l t r a n s p o r t - of r e c e p t o r s , 185 Benzodiazepine c o m p l e x - b i n d i n g of ( 3 s S ) T B P S , Benzodiazepine r e c e p t o r , 145 Benzodiazepines - interaction with a histadine Bicuculline - e f f e c t on g l y c e r o l i p i d , 397 B i n d i n g - of 3 H - G A B A , 115 B i n d i n g - of a H - m u s c i m o l , 179 B i n d i n g - of 3 H - t r y p t o p h a n , 25

377 residue,

C - A M P - e n h a n c e s g e n e e x p r e s s i o n , 259 C-AMP dependent phosphorylation, 161 C - D N A c l o n i n g - of G A B A a r e c e p t o r , 33 C a l c i u m - e f f e c t on a c e t y l c h o l i n e m e t a b o l i s m , 403 C a l c i u m - e f f e c t on c i t r a t e m e t a b o l i s m , 403 C a l c i u m b i n d i n g p r o t e i n , 381 C a l m o d u l i n - e f f e c t of 3 H - g l u t a m a t e a c c u m u l a t i o n , 17 C a l m o d u l i n - e f f e c t on 3 H - g l u t a m a t e b i n d i n g , 17 C a l p a i n II - a c t i v i t y w i t h c a s e i n , 307 C a l p a i n II - r e g i o n a l d i s t r i b u t i o n , 307 C a l p a s t a t i n - a c t i v i t y in p r e s e n c e of casein, 307 Calpastatin - regional distribution, 307 ~-carbolines - interaction with benzodiazepine receptor, C a r p b r a i n - m u s c a r i n i c system, 511 C a s e i n - e f f e c t on c a l p a i n II a c t i v i t y , 307 C a s e i n - e f f e c t on c a l p a s t a t i n a c t i v i t y , 307 Catecholamine l e v e l s - e f f e c t of x - i r r a d i a t i o n , 97 C a t i o n i c c u r r e n t s - of g o n a d o t r o p h cells, 265 C a t i o n s - e f f e c t on GFAP, 421 3 H - C D - b i n d i n g to m u s c a r i n i c r e c e p t o r s , 333 Cholecystokinin o c t o p e p t i d e s u l f a t e - i m m u n o a s s a y , 55 Choline acetyltransferase - in c a r p brain, 511 xi

145

145

xii

Index

C h o l i n e r g i c m a r k e r s - e f f e c t of h e m i c h o l i n i u m analogs, 531 C h o l i n e s t e r a s e - release, 199 Cholinesterase activity - measurement, 199 3H-(+)-cis-methyldioxolane - see sH-CD, 333 C i t r a t e m e t a b o l i s m - e f f e c t of calcium, 403 C i t r a t e m e t a b o l i s m - in s y n a p t o s o m e s , 403 C l o n i n g - of h u m a n G A B A a r e c e p t o r , 33 C o c h l e a r n u c l e u s - l o c a l i s a t i o n of c a l c i u m b i n d i n g , 381 Cryopreservation - d o p a m i n e r e l e a s e , 349 2',3'-cyclic nucleotide 3'phosphohydrolase - in g l i a l cells, C y c l o s p o r i n A - e n h a n c e s n e u r o t o x i c i t y of MPTP, 249

239

D - v a l i n e - i n h i b i t s f i b r o b l a s t g r o w t h , 365 D1 r e c e p t o r s - b i n d i n g studies, 321 D2 r e c e p t o r s - b i n d i n g studies, 321 D o p a m i n e - a c t i o n on s e r o t o n i n - N - a c e t y l t r a n s f e r a s e , 549 D o p a m i n e b e h a v i o u r s , 107 D o p a m i n e c o n t e n t - e f f e c t of x - i r r a d i a t i o n , 97 D o p a m i n e n e u r o n e s - e f f e c t of n e u r o t o x i n s , 127 D o p a m i n e r e c e p t o r s - on s y n a p t o s o m e s , 339 D o p a m i n e r e l e a s e - e f f e c t of u r i d i n e , 107 D o p a m i n e r e l e a s e - f r o m s t r i a t a l slices, 107 Dopamine release - from synaptosomes, 349 D o p a m i n e u p t a k e sites - b i n d i n g of 3 H - G B R 12935, 325 Dopamine-~-hydoxylase - a x o n a l t r a n s p o r t , 39 Dopamine-~-hydoxylase - subcellular distribution, 39 Dopamine-~-hydroxylase a c t i v i t y - in v e s i c l e s , 445 D o p a m i n e r g i c n e u r o n e s - e f f e c t of MPP+, 223 E l e c - 3 9 - m o n o c l o n a l a n t i b o d y , 517 E t h a n o l - e f f e c t on m u s c a r i n i c r e c e p t o r s , 91 E x c i t a t o r y a m i n o a c i d r e c e p t o r s - a n d p r o t e i n k i n a s e C, 131 E x c i t a t o r y a m i n o acids, 1 Excitatory amino acids - phosphoinositide h y d o l y s i s , 131 E x c i t a t o r y a m i n o a c i d s - r e c e p t o r s l i n k e d to i n o s i t o l p h o s p h a t e s , Excitatory amino acids - receptors, 1 E x p r e s s i o n of G F A P mRNAs, 215 E x p r e s s i o n of t u b u l i n mRNAs, 215 F a t t y acyl g r o u p s - f r o m p h o s p h a t i d e s to o p i a t e ligands, F a t t y a c y l - C o A - e l o n g a t i o n a n d c o n d e n s a t i o n , 497 F a t t y a c y l - C o A - in j i m p y m o u s e , 497 F i b r o b l a s t g r o w t h - i n h i b i t e d b y D - v a l i n e , 365

207

3 H - G A B A b i n d i n g - in D r o s o p h i l a CNS m e m b r a n e s , 115 GABA regulates serotonin-N-acetyltransferase, 549 GABA r e g u l a t i o n of s e r o t o n i n - N - a c e t y l t r a n s f e r a s e , 541 G A B A d i s p l a c e a b l e S H - m u s c i m o l b i n d i n g , 179 G A B A a r e c e p t o r - c l o n i n g of c-DNA, 33 GABAb receptors - negative coupling with phosphatidylinositol t u r n o v e r , 359 G a n g l i o s i d e - uptake, 455 3 H - G B R 12935 b i n d i n g - to d o p a m i n e u p t a k e sites, 325 Sene e x p r e s s i o n - e f f e c t of c-AMP, 259 G e n e s t r u c t u r e - of p h e n y l e t h a n o l a m i n e - N - m e t h y l t r a s f e r a s e , 555 G F A P - e f f e c t of m e t a b o l i c c a t i o n s , 421 GFAP e f f e c t of pH, 421 G F A P mRNAs, 215 G l i a l f i b r i l l a r y a c i d p r o t e i n - see GFAP, 421 3 H - g l u t a m a t e - a c c u m u l a t i o n a n d b i n d i n g , 17 3 H - g l u t a m a t e a c c u m u l a t i o n - e f f e c t of c a l m o d u l i n , 17 3 H - g l u t a m a t e b i n d i n g - f r o m rat a d r e n a l , 137 3 H - g l u t a m a t e b i n d i n g - q u i s q u a l a t e s e n s i t i v e , 137 3 H - g l u t a m a t e u p t a k e - e f f e c t of c a l m o d u l i n , 17 G l u t a m a t e - i n h i b i t s p r o t e i n s y n t h e s i s , 293 G l u t a m i n e s y n t h e t a s e - in g l i a l cells, 239 -

-

-

1

Index

xiii

G l y c e r o l i p i d - e f f e c t of b i c u c u l l i n e , 3~-7 G l y c e r o l i p i d - e f f e c t of v a l p r o i c acid, 397 G l y c e r o l i p i d - f o r m a t i o n , 397 GMI g a n g l i o s i d e - u p t a k e , 455 G o n a d o t r o p h c e l l s - c a t i o n i c c u r r e n t s , 265 G o n a d o t r o p h c e l l s - in c u l t u r e , 265 H a l o p e r i d o l t r e a t m e n t - u r i d i n e e f f e c t s on b e h a v i o u r , 107 Hemicholinium a n a l o g s - e f f e c t on c h o l i n e r g i c a n d a n d GABAergic systems, 531 H i s t i d i n e r e s i d u e - of B e n z o d i a z e p i n e r e c e p t o r , 145 H N K - I - m o n o c l o n a l a n t i b o d y , 517 H P L C - f o r d e t e r m i n i n g t a u r i n e , 429 5-HT - a n a l y s i s b y m i c r o d i a l y s i s , 503 5-HT - in f r e e l y m o v i n g rats, 503 5-hydroxyindoleacetic acid - analysis by microdialysis, 503 5-hydroxyindoleacetic a c i d - in f r e e l y m o v i n g rats, 503 6-hydroxydopamine - e f f e c t on d o p a m i n e n e u r o n e s , 127 6-hydroxydopamine - n e u r o t o x i n , 127 Hypoxic/hyptensive rats - r e l e a s e of p u r i n e s , 485 I m m u n o a s s a y - Of c h o l e c y s t o k i n i n , 55 I n o s i t o l p h o s p h a t e - in n e o n a t a l rat s t r i a t u m , 1 I n o s i t o l p h o s p h a t e - r e c e p t o r s of e x c i t a t o r y a m i n o acids, 1 Inositol phosphates - receptors, 1 I n o s i t o l p h o s p h o l i p i d b r e a k d o w n - in S H - S Y S Y cells, 73 I n s e c t n e r v o u s s y s t e m - b i n d i n g of 3 H - s a x i t o x i n , 391 Jimpy

mouse

- fatty

acyl-CoA,

497

Luteinizing Luteinizing

hormone hormone

- r e g u l a t i o n of s t e r o i d r e c e p t o r s , - s y n t h e s i s of s u b u n i t s , 259

277

MAO -inhibited by N-methylisoquinolinium ion, 315 Methylserotonin - in s y n a p t o s o m e s , 227 l-methyl-4-phenylpyridiniu~ ion [MPP+] - e f f e c t on dopaminergic n e u r o n e s in g o l d f i s h retina, 223 N-methyl-4,phenyl-l,2,3,6-tetrahydropyridine (MPTP) - see, 249 N-methylisoquinolinium ion - i n h i b i t o r of a r o m a t i c - L - a m i n o acid decarboxylase, 315 N-methylisoquinolinium ion - i n h i b i t o r of MA0, 315 N-methylisoquinolinium ion - i n h i b i t o r of t y r o s i n e - h y d r o x y l a s e , 315 N-methylscopolamine - b i n d i n g , 301 N-methylscopolamine k i n e t i c s of i n t e r a c t i o n with muscarinic r e c e p t o r s , 301 M o d u l a t i o n - of a c e t y l c h o l i n e release, 9 Monoaminergic l e v e l s - e f f e c t of M P P + in retina, 223 M o n o c l o n a l a n t i b o d i e s - to a c e t y l c h o l i n e s t e r a s e , 517 MPP+ e f f e c t on m o n o a m i n e l e v e l s in g o l d f i s h retina, 223 MPTP neurotoxicity - e n h a n c e d b y c y c l o s p o r i n A, 249 MRNA of p h e n y l e t h a n o l a m i n e - N - m e t h y l t r a n s f e r a s e , 555 MRNAs f r o m t u b u l i n a n d G F A P in a s t r o c y t e s , 215 M u s c a r i n i c r e c e p t o r s - e f f e c t of e t h a n o l , 91 M u s c a r i n i c a n t a g o n i s t s - e f f e c t on a u t o r e c e p t o r s , 153 Muscarinic autoreceptors, 153 Muscarinic autoreceptors - e f f e c t of a n t a g o n i s t s , 153 M u s c a r i n i c c o m p o n e n t s - in c a r p brain, 511 Muscarinic receptors, 9 Muscarinic receptors - autoradiography, 91 M u s c a r i n i c r e c e p t o r s - b i n d i n g of 3 H - Q N B a n d 3H-CD, 333 M u s c a r i n i c r e c e p t o r s - c o u p l e d to i n o s i t o l p h o s p h a t e s , 73 M u s c a r i n i c r e c e p t o r s - do not s e n s i t i z e , 9 M u s c a r i n i c r e c e p t o r s - e f f e c t of s c o p o l a m i n e t r e a t m e n t , 333 M u s c a r i n i c r e c e p t o r s - e f f e c t of t r i m e t h y l tin i n t o x i c a t i o n , 475 Muscarinic receptors - interaction with N-methylscopolamine, 301 Muscarinic receptors - modulates acetylcholine release, 9 Muscarinic receptors - quantitative autoradiography, 475 S H - m u s c i m o l b i n d i n g - s e n s i t i v i t y to GABA, 179 -

-

-

xiv

Index N a B r t r e a t m e n t - e f f e c t of a c e t y l c h o l i n e s t e r a s e , 157 NC-I - monoclonal-antibody, 517 Neurofilament proteins - phosphorylation, 467 N e u r o f i l a m e n t p r o t e i n s - i n n e u r o n e s , 467 N e u r o p e p t i d e Y - s u b c e l l u l a r d i s t r i b u t i o n , 39 N e u r o t o x i n s - e f f e c t o n d o p a m i n e n e u r o n e s , 127 N o r a d r e n a l i n e - a x o n a l t r a n s p o r t , 39 N o r a d r e n a l i n e - s u b c e l l u l a r d i s t r i b u t i o n , 39 N o r a d r e n a l i n e c o n t e n t - e f f e c t of x - i r r a d i a t i o n , 97 N o r a d r e n e r g i c s t o r a g e v e s i c l e s , 445 N u c l e o t i d e s e q u e n c e s - of G A B A a r e c e p t o r a - s u b u n i t , 33 O l i g o d e n d r o c y t e s - e f f e c t of t h y r o i d d e f i c i e n c y o n c e l l m a r k e r s , 239 " O n - l i n e " - m e a s u r e of c h o l i n e s t e r a s e a c t i v i t y r e l e a s e , 199 O p i a t e l i g a n d s - t r a n s f e r of f a t t y a c y l g r o u p s f r o m p h o s p h a t e s , 207 O r n i t h i n e d e c a r b o x y l a s e a c t i v i t y , 433 O r n i t h i n e d e c a r b o x y l a s e a c t i v i t y - s u b c e l l u l a r d i s t r i b u t i o n , 433 P a l m i t a t e - in n o r m a l a n d t r e m b l e r m i c e , 61 P a l m i t a t e - u p t a k e a n d m e t a b o l i s m , 61 P a t c h - c l a m p - of g o n a d o t r o p h s , 265 Phenylethanolamine-N-methyltransferase g e n e - m R N A , 555 Phenylethanolamine-N-methyltransferase g e n e - s t r u c t u r e , 555 P h o s p h a t i d e s - t r a n s f e r of f a t t y a c y l g r o u p s to o p i a t e l i g a n d s , 207 Phosphatidylinositol turnover - negatively coupled with GABAb r e c e p t o r s , 359 P h o s p h o i n o s i t i d e h y d r o l y s i s - e f f e c t of e x c i t a t o r y a m i n o acids, 131 P h o s p h o r y l a t i o n - of n e u r o f i l a m e n t p r o t e i n s , 467 P h o s p h o r y l a t i o n - c - A M P d e p e n d e n t p r o c e s s , 161 P h o s p h o r y l a t i o n - in l e e c h CNS, 161 P h o s p h o r y l a t i o n - of 79 k D a p r o t e i n , 161 P i t u i t a r y c e l l a g g r e g a t e s , 277 P i t u i t a r y c e l l s - in t i s s u e c u l t u r e , 259 P r o t e i n k i n a s e C - a n d n e o n a t a l e x c i t a t o r y a m i n o a c i d s , 131 P r o t e i n s y n t h e s i s - i n h i b i t e d b y g l u t a m a t e , 293 P r o t e o l i p i d a n t i g e n s - at T o r p e d o n e u r o m u s c u l a r s y n a p s e s , 169 Proteolipids - immunohistochemical l o c a l i s a t i o n , 169 Purine release effect of 5-aminoimidazole-4-carboxamide r i b o s i d e , 485 Purine release - from hypoxic/hypotensive r a t c o r t e x , 485 Pyroglutamyl peptidase II a thyrotropin release hormone d e g r a d i n g e n z y m e , 81 P y r o g l u t a m y l p e p t i d a s e II - p r o p e r t i e s , 81 P y r u v a t e d e h y d r o g e n a s e - a c t i v i t y , 355 3H-(-)-quinuclidinyl Quisqualate - effect

b e n z i l a t e - s e e 3 H - Q N B , 333 on 3 H - g l u t a m a t e b i n d i n g , 137

R e c e p t o r s - a n d a x o n a l t r a n s p o r t , 185 R e c e p t o r s - f o r s t e r o i d s , 277 Receptors - to excitatory amino acids, 1 R e l e a s e - of a c e t y l c h o l i n e , 9 R e l e a s e - of a d e n o s i n e d e r i v a t i v e s , 4 1 1 R e t i n a - d o p a m i n e r g i c n e u r o n e s , 223 R e t i n a - r e l e a s e of a d e n o s i n e d e r i v a t i v e s , 4 1 1 Retina - serotonin-N-acetyltransferase, 541 3 H - s a x i t o x i n - b i n d i n g sites, 391 3 H - s a x i t o x i n - b i n d i n g to s o d i u m c h a n n e l , 391 S c o p o l a m i n e - c h r o n i c e f f e c t o n m u s c a r i n i c r e c e p t o r s , 333 S e c r e t o g r a n i n II - a g o n a d o t r o p h p o l y p e p t i d e , 277 S e c r e t o g r a n i n II - r e g u l a t e d b y s t e r o i d r e c e p t o r s , 277 S e r o t o n i n r e c e p t o r s - o n s y n a p t o s o m e s , 339 Serotonin-N-acetyltransferase - in r e t i n a , 541, 549 Serotonin-N-acetyltransferase - r e g u l a t e d b y GABA, 541, 549 S H - S Y S Y n e u r o b l a s t o m a c e l l s - m u s c a r i n i c r e c e p t o r s , 73 S o d i u m c h a n n e l s - b i n d i n g of 3 H - s a x i t o x i n , 391

Index

xv

S t e r o i d r e c e p t o r s , 277 S t e r o i d r e c e p t o r s - r e g u l a t e l u t e i n i z i n g h o r m o n e , 277 Steroid receptors - regulate secretogranin II, 277 S y n a p t o s o m a l d o p a m i n e r e l e a s e - f r o m c r y o p r e s e r v e d tissue, 349 S y n a p t o s o m a l d o p a m i n e r e l e a s e - f r o m p o s t m o r t e m brain, 349 Synaptosomes - acetylcholine s y n t h e s i s , 403 S y n a p t o s o m e s - b e h a v i o u r of a - m e t h y l s e r o t o n i n , 227 S y n a p t o s o m e s - d o p a m i n e a n d s e r o t o n i n r e c e p t o r d i s t r i b u t i o n , 339 S y n a p t o s o m e s - d o p a m i n e r e l e a s e , 349 S y n a p t o s o m e s - f r o m rat c e r e b r a l cortex, 293 S y n a p t o s o m e s - m o r p h o l o g y in d i f f e r e n t f r a c t i o n s , 339 S y n a p t o s o m e s - p r o t e i n s y n t h e s i s , 293 S y n a p t o s o m e s - a d e n y l a t e c y c l a s e a c t i v i t y , 339 S y n a p t o s o m e s - in d i f f e r e n t f r a c t i o n s , 339 Taurine - determination, 429 (35S)t-butyl bicylophosphosphorothionate - see ( 3 5 S ) T B P S ( 3 s S ) T B P S - b i n d i n g to b e n z o d i a z e p i n e c o m p l e x , 377 (±)Tetrahydroanisocycline - b i n d i n g to D1 a n d D2 r e c e p t o r s , 321 (±)Tetrahydropalmatine - b i n d i n g to D1 a n d D2 r e c e p t o r s , 321 T h i a m i n e d e f i c i e n c y - e f f e c t on s p e c i f i c e n z y m e s , 439 T h i a m i n e d e p e n d e n t e n z y m e s , 439 T h y r o i d d e f i c i e n c y - a n d m a t u r a t i o n of g l i a l cells, 239 T h y r o i d d e f i c i e n c y - r e l a t e d to m a r k e r s for a s t r o c y t e s , 239 Thyrotropin release hormone degrading enzyme - pyroglutamyl p e p t i d a s e II, 81 Torpedo neuromuscular s y n a p s e s - p r o t e o l i p i d a n t i g e n , 169 T r e m b l e r m i c e - u p t a k e a n d m e t a b o l i s m of p a l m i t a t e , 61 T r i m e t h y l t i n i n t o x i c a t i o n - e f f e c t on m u s c a r i n i c r e c e p t o r s , 475 3 H - t r y p t o p h a n - b i n d i n g , 25 T u b u l i n m R N A s , 215 Tyrosine hydroxylase - inhibited by N-methylisoquinolinium ion, 315 U p t a k e - of p a l m i t a t e , 61 U r i d i n e - e f f e c t on d o p a m i n e r e l e a s e a n d b e h a v i o u r , 107 U r i d i n e e f f e c t s - f o l l o w i n g h a l o p e r i d o l t r e a t m e n t , 107 U r i d i n e t r e a t m e n t - h a l o p e r i d o l e f f e c t s on b e h a v i o u r , 107 Valproic Vesicles Vesicles Vesicles

a c i d - e f f e c t on g l y c e r o l i p i d , 397 - containing noradrenaline, 445 - dopamine-~-hydroxylase, 445 - f r o m cat ovary, 445

X-irradiation

- effect

on d o p a m i n e

and noradrenaline,

PRINTED IN GREAT BRITAIN BY BPCC WHEATONS LTD, EXETER

97

643